Merck Group Competitors and Similar CompaniesClear all
Merck's competitors and similar companies include Johnson & Johnson, Pfizer and AbbVie.
 Merck Merck (also known as MSD) is a company that develops and manufactures medicines and vaccines for human and animal health. |  Johnson & Johnson Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  AbbVie AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies. | |
Founding Date | Founding Date 1891 | Founding Date 1886 | Founding Date 1849 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Rahway, US HQ Munro, AR Macquarie Park, AU Krems An Der Donau, AT Wien, AT Bruxelles, BE Santa Cruz De La Sierra, BO see more | Locations New Brunswick, US HQ Buenos Aires, AR Sydney, AU Vienna, AT Minsk, BY Beerse, BE Sofia, BG see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations North Chicago, US HQ Hydra, DZ Buenos Aires, AR Mascot, AU Wien, AT Wavre, BE Sarajevo, BA see more |
Employees | Employees 73,0004% increase | Employees 138,1005% increase | Employees 81,0008% decrease | Employees 55,00010% increase |
Valuation ($) | Valuation ($) 294.7 b | Valuation ($) 396.3 b | Valuation ($) 163.9 b | Valuation ($) 335 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $65b (FY, 2025) | Revenue (est.) $94.2b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) $61.2b (FY, 2025) |
Cost of goods | Cost of goods $16.4b (FY, 2025) | Cost of goods $30.3b (FY, 2025) | Cost of goods $16.1b (FY, 2025) | Cost of goods $18.2b (FY, 2025) |
Gross profit | Gross profit $48.6b (FY, 2025) | Gross profit $63.9b (FY, 2025) | Gross profit $46.5b (FY, 2025) | Gross profit $43b (FY, 2025) |
Net income | Net income $18.3b (FY, 2025) | Net income $26.8b (FY, 2025) | Net income $7.8b (FY, 2025) | Net income $4.2b (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries N/A | Countries N/A | Countries 200 (FY, 2024) | Countries 70 (FY, 2022) |
Manufacturing Facilities (United States) | Manufacturing Facilities (United States) N/A | Manufacturing Facilities (United States) 28 (FY, 2022) | Manufacturing Facilities (United States) N/A | Manufacturing Facilities (United States) 11 (FY, 2022) |
Phase II Trials Products | Phase II Trials Products 85 (FY, 2022) | Phase II Trials Products N/A | Phase II Trials Products 27 (FY, 2024) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products 32 (FY, 2022) | Phase III Trials Products N/A | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products N/A |
For sources of this data, please see the company profile
View Company Profiles
Johnson & Johnson
HQ
New Brunswick, US
Employees
138,100↑ 5% increase
Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field.
View companyPfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View companyAbbVie
HQ
North Chicago, US
Employees
55,000↑ 10% increase
AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies.
View company